Related Experiment Video
Updated: Sep 20, 2025

Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery
Published on: November 28, 2018
Impact of Left Ventricular Diastolic Pressure Changes on Clinical Outcomes After Transcatheter Aortic Valve
Jiwon Seo1, Ah-Ram Kim2, Iksung Cho3
1Division of Cardiology, Department of Internal Medicine, Gangnam Severance Hospital Yonsei University College of Medicine Seoul Republic of Korea.
Abstract:
Changes in left ventricular (LV) diastolic pressure after transcatheter aortic valve replacement (TAVR) or their relationship with subsequent outcomes remain poorly clarified. Accordingly, we aimed to assess the changes in invasively measured LV diastolic pressure and their relationship with long-term outcomes in patients undergoing TAVR.
Methods:
In total, 509 patients with severe aortic stenosis who underwent TAVR at 3 tertiary centers were retrospectively included and divided into 2 groups according to changes in LV pre-A pressure after TAVR: Group 1, with no change or decrease in pre-A pressure, and Group 2, presenting an increase in pre-A pressure after TAVR. The primary outcome was a composite of all-cause death and rehospitalization for heart failure.
Results:
Group 1 included 39% (n=198) patients, and Group 2 had 61% (n=311) patients. More patients in Group 2 had diabetes, chronic kidney disease, and a larger aortic valve area than in Group 1. During the follow-up period (median, 28 months), 122 primary outcomes were recorded. In Kaplan-Meier analysis, the cumulative incidence of the primary outcome and all-cause death was significantly lower in Group 1 than in Group 2. In multivariable Cox hazard models, Group 1 was independently associated with a favorable primary outcome (hazard ratio, 0.52 [95% CI, 0.34-0.80]; P=0.003).
Conclusions:
Increase in LV pre-A pressure after TAVR is common, and no change or decrease in LV pre-A pressure after TAVR is independently associated with favorable outcomes. Changes in LV pre-A pressure can help identify patient subsets who will maximally benefit from TAVR.
Related Concept Videos
Aortic Regurgitation III: Medical Management
Aortic Regurgitation I: Introduction
Mitral Stenosis I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Measurement of Blood Pressure
Mitral Regurgitation I: Introduction

